Fushimi Pharmaceutical Co., Ltd. No.171803
α2,3-Sialylglycopeptide
Creation Date : 12/JUN/2014
Revision Date : 17/MAR/2020

ＳＤＳSafety Date Sheet

1. Chemical Product and Company Identification
Product nameProduct code
Manufacturer/Supplier name
Address
Telephone number
Fax number
E-mail address
Emergency telephone number: α2,3-Sialylglycopeptide: 171803: Fushimi Pharmaceutical Co., Ltd.
: 307 Minatomachi, Marugame, Kagawa 763-0042: 81-87-899-7743: 81-877-22-6280: info@fushimi.co.jp: 81-3-6361-9121

2. Hazards Identification
GHS classification
Physical hazards
Health hazards
Environmental hazards: Not available: Not available: Not available

Allocation of Label Elements
Hazard symbols
Signal word
Hazard statements
Precautionary statements
Other hazards: Not available: Not available: Not available: Not available: Not available

3. Composition/Information on Ingredients
Substance/mixture
Chemical nameContents
CAS No.
Synonym
Chemical formula
Molecular weight: Substance: α2,3-Sialylglycopeptide: ＞95.0 % (HPLC):: α2,3-Sialylglycopeptide: C112H189N15O70: 2865.78

4. First Aid Measures
After inhalation :If inhaled, remove to fresh air. If breathing becomes difficult, call a physician.
After skin contact :In case of contact, immediately wash skin with soap and copious amounts of water.
After eye contact :In case of contact with eyes, flush with copious amounts of water for at least 15 minutes. Assure
adequate flushing by separating the eyelids with fingers. Get medical attention.
After ingestion :If swallowed, wash out mouth with water provided person is conscious. Get medical attention.

5. Fire Fighting Measures
Extinguishing media :Suitable: Water spray, dry chemical powder.
Prohibited extinguishing media :Date not available.
Specific hazards arising from the chemical :1/4

Fushimi Pharmaceutical Co., Ltd. No.171803
α2,3-Sialylglycopeptide
Creation Date : 12/JUN/2014
Revision Date : 17/MAR/2020

Emits toxic fumes under fire conditions.
Special protective equipment and precautions for fire-fighters :Wear self-contained breathing apparatus and protective clothing to prevent contact withskin and eyes.

6. Accidental Release Measures
Personal precautions :Exercise appropriate precautions to minimize direct contact with skin or eyes and preventinhalation of dust.
Environmental precautions :Do not let product enter the drains.
Methods for cleaning up :Sweep up, place in a bag and hold for waste disposal. Avoid raising dust. Ventilate area and wash
spill site after material pickup is complete.

7. Handling and Storage
Handling :Handle with appropriate personal protective equipment under ventilation.
Avoid inhalation. Avoid contact with eyes, skin, and clothing.
Wash thoroughly after handling.
Storage :Store in Freezer. The container tightly closed.
Avoid heat and humidity. Store in a separate from oxidizing agents.

8. Exposure Controls /Personal Protection
Control Parameters :Date not available.
Engineering controls :Safety shower and eye bath. Mechanical exhaust required.
General hygiene measures :Wash thoroughly after handling.
Personal protective equipment :Respiratory protection : Wear dust mask.
Hand protection: Wear appropriate protective gloves.
Eye protection: Wear appropriate protective eyeglasses or chemical safety goggles.
Skin protection: Wear appropriate protective gloves.

9. Physical and Chemical Properties
AppearanceOdor
pH
Melting point/freezing point
Boiling point/range
Flash point
Evaporation Rate
Flammability or explosive limits
Vapor pressure
Vapor Density
Relative density
Solubility
Log Pow
Spontaneousignition temperature
Decomposition temperature
Viscosity: White powder: Odorless: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available
2/4

Fushimi Pharmaceutical Co., Ltd. No.171803
α2,3-Sialylglycopeptide
Creation Date : 12/JUN/2014
Revision Date : 17/MAR/2020

10. Stability and Reactivity
Reactivity
Chemical Stability
Possibility of Hazardous Reaction

Conditions to avoid
Incompatible materials
Hazardous decomposition products: Special reactive has not been reported.
: This product is stable under normal conditions ofhandling and storage.
: Under fire conditions, harmful decomposition products
such as carbon monoxide and nitrogen oxide might begenerated.
: Extremely high temperature.
All heat sources (hot, spark, and flame).
: Strong oxidizing agents: Under fire conditions, harmful decomposition products
such as carbon monoxide, carbon dioxide and nitrogenoxide might be generated.

11. Toxicological Information
Routes of Exposure
SymptomsToxicity
Acute toxicity
Skin irritation/corrosion
Serious eye damage/irritation
Respiratory or skin sensitization
Reproductive cell mutagenicity
Carcinogenicity
Reproductive toxicity
Specific target organ toxicity(single exposure)Specific target organ toxicity(repeated exposure)
Aspiration hazard: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available

12. Ecological Information
Ecotoxicity
Fish Toxicity
Earthworm Toxicity
Algal Growth Inhibition Test
Acute Immobilization Test
Persistance/degradability
Bioaccumulative potential
Mobility in soil
Results of PBT and vPvB Assessment
Other adverse effects: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available: Not available

13. Disposal Considerations
Observe all federal, state, and local environmental regulations. Do not dump this product into sewers,
on the ground or into any body of water. Contact a licensed professional waste disposal service todispose of this material. Dissolve or mix the material with a combustible solvent and burn in achemical incinerator equipped with an afterburner and scrubber.

14. Transport Information
UN Number
Shipping Name
Hazard Class
Packing Group
Hazard Labels: Not listed::: No information available: No information available
3/4

Fushimi Pharmaceutical Co., Ltd. No.171803
α2,3-Sialylglycopeptide
Creation Date : 12/JUN/2014
Revision Date : 17/MAR/2020

IMO
IATARID/ADR: Non-hazardous material: Non-hazardous material: Non-hazardous material

15. Regulatory Information.
TSCA:ENCS:ISHL:Please refer to any other federal, state and local regulations.

16. Other Information
Warranty
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of ourknowledge and is applicable to the product with regard to appropriate safety precautions. It does
not represent any guarantee of the properties of the product. Fushimi Pharmaceutical Co., Ltd.
shall not be held liable for any damage resulting from handling or from contact with the above
product. See reverse side of invoice or packing slip for additional terms and conditions of sale.
Disclaimer
For R&D use only. Not for drug, household or other uses.

4/4